1. T.08.1 CHARACTERISTICS AND PREDICTORS OF LIVER TOXICITY IN ADVANCED BREAST CANCER PATIENTS TREATED WITH CYCLINDEPENDENT KINASE INHIBITORS: AN OBSERVATIONAL STUDY. (May 2022) Authors: Ciaccio, A.; Scaravaglio, M.; Laffusa, A.; Lucà, M.; Longo, S.; Manna, M.; Maggioni, C.; Riva, F.; Cicchiello, F.; Cazzaniga, M.E.; Cortinovis, D.L.; Invernizzi, P. Journal: Digestive and liver disease Issue: Volume 54(2022)Supplement 2 Page Start: S146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now?. (3rd December 2017) Authors: Cazzaniga, M. E.; Cortesi, L.; Ferzi, A.; Scaltriti, L.; Cicchiello, F.; Ciccarese, M.; Torre, S. Della; Villa, F.; Giordano, M.; Verusio, C.; Nicolini, M.; Gambaro, A. R.; Zanlorenzi, L.; Biraghi, E.; Casini, E.; Legramandi, L.; Rulli, E. Other Names: Harris Eleanor E. R. Academic Editor. Journal: International journal of breast cancer Issue: Volume 2017(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study. (October 2017) Authors: Alù, M.; Ancona, C.; Andreis, D.; Bajardi, E.; Benedetto, C.; Berardi, R.; Bordin, E.; Butti, C.; Capri, G.; Cicchiello, F.; Cocciolone, V.; Dester, M.; D'Onofrio, L.; Febbraro, A.; Ferrarini, I.; Fotia, V.; Gervasi, E.; Guaitoli, G.; Licata, L.; Liscia, N. Journal: Breast Issue: Volume 35(2017) Page Start: 115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗